Stock Research: Raia Drogasil

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Raia Drogasil

BOVESPA:RADL3 BRRADLACNOR0
20
  • Value
    36
  • Growth
    53
  • Safety
    Safety
    21
  • Combined
    12
  • Sentiment
    50
  • 360° View
    360° View
    20
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Raia Drogasil S/A is a Brazilian company focused on the retail sale of pharmaceutical and cosmetic products. It operates in the retail pharmacy industry, selling branded and generic medications, OTC medications, and personal hygiene products. The company primarily operates in Brazil, across all federal units. In the last fiscal year, the company had a market cap of $4,152 million, profits of $1,871 million, and revenue of $6,292 million, with 64758 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 20 (better than 20% compared with alternatives), overall professional sentiment and financial characteristics for the stock Raia Drogasil are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Raia Drogasil. The consolidated Growth Rank has a good rank of 53, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 53% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 50, which means that professional investors are more optimistic about the stock than for 50% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 21, which means that the share price of Raia Drogasil is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 79% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 36, which means that the company has a financing structure that is riskier than those of 64% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
BOVESPA
Independent Boards Growth Markets
Renewables Users
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
21 19 7 11
Growth
53 55 97 83
Safety
Safety
36 57 50 48
Sentiment
50 46 77 85
360° View
360° View
20 37 60 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
30 44 45 26
Opinions Change
70 35 50 64
Pro Holdings
n/a 55 73 93
Market Pulse
34 67 84 68
Sentiment
50 46 77 85
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
21 19 7 11
Growth
53 55 97 83
Safety Safety
36 57 50 48
Combined
12 32 50 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
20 29 15 32
Price vs. Earnings (P/E)
56 49 25 36
Price vs. Book (P/B)
24 22 11 20
Dividend Yield
29 22 15 15
Value
21 19 7 11
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
94 92 90 75
Profit Growth
22 30 71 78
Capital Growth
87 82 65 69
Stock Returns
9 23 81 19
Growth
53 55 97 83
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
30 38 40 38
Refinancing
57 62 57 53
Liquidity
32 44 43 60
Safety Safety
36 57 50 48

Similar Stocks

Discover high‑ranked alternatives to Raia Drogasil and broaden your portfolio horizons.

Lojas Renner

BOVESPA:LREN3
Country: Brazil
Industry: Apparel Retail
Size: Medium
Full Stock Analysis

Puregold Price Club

PSE:PGOLD
Country: Philippines
Industry: Hypermarkets, Super Centers
Size: Medium
Full Stock Analysis

Vodacom

JSE:VOD
Country: South Africa
Industry: Wireless Telecommunication
Size: X-Large
Full Stock Analysis

Localiza Rental Car

BOVESPA:RENT3
Country: Brazil
Industry: Trucking
Size: Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.